Phar­ma in­dus­try rep­u­ta­tion re­mains steady at a ‘new nor­mal’ af­ter Covid, Har­ris Poll finds

The phar­ma in­dus­try is hang­ing on to rep­u­ta­tion gains notched dur­ing the Covid-19 pan­dem­ic. Pos­i­tive per­cep­tion of the phar­ma in­dus­try is steady at 45% of US re­spon­dents in 2023, ac­cord­ing to the lat­est Har­ris Poll da­ta. That’s ex­act­ly the same as the pre­vi­ous year.

Phar­ma’s high­est point was in Feb­ru­ary 2021 — as Covid vac­cines be­gan to roll out — with a 62% pos­i­tive US per­cep­tion, and help­ing the in­dus­try land at an av­er­age 55% pos­i­tive sen­ti­ment at the end of the year in Har­ris’ 2021 an­nu­al as­sess­ment of in­dus­tries. The phar­ma in­dus­try’s rep­u­ta­tion hit its most re­cent low at 32% in 2019, but it had hov­ered around 30% for more than a decade be­fore.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER